CVRx
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, CVRx sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,751 sponsors by registered trial count).
CVRx: 6 sponsored US clinical trials, none currently recruiting.
CVRx sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Heart Failure, with 1 trials.
Upper-quartile sponsor footprint
CVRx sits in the upper quartile of the sponsor corpus (#2,085 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT04502316
Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence
NCT05860348
BATwire Implant Kit
NCT04600791
Baroreflex Activation Therapy for Heart Failure
NCT02627196
Rheos System for the Treatment of HFpEF Heart Failure
NCT00957073
Rheos® Pivotal Trial
NCT00442286
Therapeutic Areas
How the CVRx archive is shaped
6 indexed studies, none listed as recruiting (0% open); 3 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Heart Failure (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.